"Cohesion, Innovation and Transformation" - Foncoo Pharmaceutical's 2019 Work Summary and Commendation Conference was successfully held
From January 6th to 8th, 2020, the 2019 Work Summary and Commendation Conference of Foncoo Pharmaceuticals was held in Shenzhen. The theme of this annual meeting is "cohesion, innovation and transformation", and the company's partner - the representative of India Reddy's representative office in China is specially invited to participate.
There are 6 sessions in this meeting, which are: 1. The sales department's performance review in 2019 and the 2020 marketing plan; 2. The finance department's fiscal and taxation training; 3. The company's chief corporate culture officer, Qin Cheng, interprets the 4.0 version of the corporate culture; 4. 2019 annual work summary and commendation meeting; 5. Reunion dinner for all employees.
2020 is a challenging year for Pangou, but we believe that as long as all Pangou people work together, innovation and transformation will be successful.
▲Sales department meeting
▲New business product knowledge training
▲Finance and taxation training
▲Interpretation of corporate culture
▲Summary of the departmental style display of the conference
▲Outstanding Commendation at the Summary Conference
▲Ten-year employee awards at the summary meeting
Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.
On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.
Official announcement! Seriously, don't be distracted!
On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.
Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.
From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".